Consultant of Department of Surgery
Chief of Divisions of Head and Neck Surgery and Plastic and Reconstructive Surgery
Queen Mary Hospital, The University of Hong Kong

​

Honorary Clinical Associate Professor

Department of Surgery

School of Clinical Medicine

Li Ka Shing Faculty of Medicine

The University of Hong Kong​

​

Velda Chow is Clinical Associate Professor of the Department of Surgery at the University of Hong Kong. She is currently Chief of Divisions of Head and Neck Surgery, and Plastic and Reconstructive Surgery. She is also Director of Burn Unit in Queen Mary Hospital and Honorary Consultant at the Hong Kong Children’s Hospital. 

​

Professor Chow obtained her Medical and Doctoral degrees from the University of Hong Kong. She received post-graduate training in Head and Neck Oncology Surgery at the University of Hong Kong, Queen Mary Hospital.

​

Her clinical and research interests focus on the management of head and neck cancer, robotic and microvascular surgery. She has delivered over 100 invited and keynote lectures, authored book chapters and published in high-impact peer-reviewed journals in the field. She has served on the editorial board of several local and international journals including Hong Kong Medical Journal, Surgical Practice, ENT Discovery and Annals of Esophagus. She was awarded the American College of Surgeons Carlos A. Pellegrini Travelling Fellowship in 2023.

​

Professor Chow was President of the Hong Kong Head and Neck Society and Secretary General of the Asian Surgical Association. She is currently Chairlady of the College of Surgeons of Hong Kong Plastic Surgery Board, Chairlady of the Hong Kong Hospital Authority Co-ordinating Committee in Surgery (COC Surgery) Specialty Group in Plastic Surgery, and mentor of the International Federation of Head and Neck Oncologic Societies (IFHNOS) Global Online Fellowship Program. She is council member of the Hong Kong Society of Plastic and Reconstructive and Aesthetic Surgeons; member of the College of Surgeons of Hong Kong Scientific Committee, Hong Kong Nasopharyngeal Cancer Study Group, and Head and Neck Cancer International Group Guidelines and Protocols Committee.